{
 "id": 14037,
 "title": "Lab Notes from an Unintentional Experiment",
 "date": {
  "submission": "2011-10-31T07:00:00.000Z",
  "experience": "1962-01-01T00:00:00.000Z"
 },
 "author": {
  "name": "Dr. James Moore",
  "gender": "Male"
 },
 "dose": [
  {
   "time": "0",
   "administration": "",
   "substance": "BZ"
  }
 ],
 "report": [
  "The following is excerpted from the 1962 lab book of Dr. James Moore, who was accidentally exposed to BZ during a BZ synthesis he was completing for the CIA. Four days after the exposure, he ingested 100 mg of acridine as an antidote.",
  "After handling the compound for about 2 days pharmacological reactions became apparent: Stumbling gait, inability to concentrate or converse effectively, dilated pupils, pink fingernails & blotchy pink hands with fingers dark pink and swollen -- very little tactile sense.  Tendency toward tremors; sudden deep breathing.  Very weak legs.  Dry skin -- no sweating; distortion of distance and time.",
  "The above symptoms were still almost full-blown on Wed 28 Nov, about 48 hours after onset (first noticed Mon. 26 Nov.",
  "Thurs. 29 Nov: Legs better, tremors fewer.  Skin still pink.  Eyes still very dilated & painful.",
  "Fri. Symptoms about the same - hands less swollen - pupils still dilated -- At 7:00 PM and 12:00 midnight took 100 mg. 5-amino-1,2,3,4 tetrahydroacridine (from K. Koniacial [spelling??] -- recx / benzene - mp. 182-183",
  "Sat Dec 4 -- pupils normal size -- better motor control although legs still weak & tired."
 ],
 "erowid": {
  "id": "93237",
  "citation": " Dr. James Moore. \"Lab Notes from an Unintentional Experiment: experience with BZ (ID 93237)\". Erowid.org. Oct 31, 2011. erowid.org/exp/93237",
  "substance": "BZ",
  "views": "9244"
 }
}
